China: China's Antitrust Regulator Ramps Up Scrutiny, Enforcement Of Behavioral Remedies

Last Updated: 15 November 2018
Article by Andrew L. Foster

In March 2018, China's State Council announced the establishment of a unified market regulator, the State Administration for Market Regulation (SAMR), which now is responsible for all antitrust enforcement in China. Previously, antitrust enforcement in China was administered by three separate ministries, each responsible for different types of cases: the National Development and Reform Commission (NDRC) handled price-related conduct cases, the State Administration of Industry and Commerce (SAIC) dealt with nonprice-related conduct cases, and the Ministry of Commerce (MOFCOM) was responsible for merger reviews.

Since the consolidation process was completed in September 2018, SAMR has been strengthening overall enforcement of the Anti-Monopoly Law (AML) in China. With respect to merger control in particular, SAMR has significantly enhanced its supervision of the behavioral remedies it has imposed in its recent conditional approvals, taking a much more active role and working closely with the monitoring trustees post-closing.

Compared to its counterparts in the United States and the European Union, SAMR (like its predecessor MOFCOM) has a much stronger preference for using behavioral remedies in its merger review process to resolve competition concerns. The most common types of behavioral remedies imposed by SAMR (and which, of course, must subsequently be monitored) include commitments to: (i) maintain supply volume and quality to Chinese customers; (ii) maintain "fair and reasonable" pricing to Chinese customers; and (iii) not engage in any illegal tying or bundling. In addition to these, SAMR has also accepted a variety of other more creative behavioral remedies.

Of the 10 latest conditional cases approved by SAMR in 2017 and 2018, only two have not had any behavioral remedy (and one of these involved China's unique "hold separate" remedy). 1 The remaining eight all entail one or more behavioral remedies: Dow/DuPont (2017), Broadcom/Brocade (2017), HP/Samsung (2017), Agrium/Potash (2017), Maersk Line/Hamburg Süd (2017), Bayer/Monsanto (2018), Luxottica/Essilor (2018) and Linde/Praxair (2018). In most of these cases, approvals were not subject to any behavioral remedies in any other reviewing jurisdiction, or they include additional China-specific behavioral remedies absent from the remedy package approved by regulators in other jurisdictions.

Depending on the company's business practice, strict compliance with these behavioral remedies may become quite burdensome both in terms of time and expenses, as compliance procedures and training must be put in place, and data collection and submission obligations are substantial. These additional operational costs can become even more pronounced given the long tenures of some of these remedy periods, which may last for five or even 10 years. Indeed, some remedies do not have a specified expiration date, meaning that the post-closing entities are bound by these remedies indefinitely until the remedies are lifted by SAMR.

These additional operational costs will be exacerbated not only by the fees for the services of the monitoring trustee (which are borne by the subject company of the remedy), but also by additional legal fees to help ensure that the company remains in compliance. These additional costs can easily run into the hundreds of thousands or even millions of dollars over a full review period.

Enhanced Supervision and Monitoring

During 2018, SAMR appears to have significantly strengthened its supervision and enforcement of behavioral remedies. Under MOFCOM, the division responsible for such monitoring was significantly understaffed and tended to delegate to the individual monitoring trustees put into place in each transaction. Now, however, its enforcement division has added several new senior officials with prior experience in some of the most high-profile merger review cases.2 In addition, former SAIC and NDRC officials — historically trained for conduct-type investigations — have also taken their place in the new Anti-Monopoly Bureau hierarchy, leading to a new focus and spotlight on post-closing compliance.

For example, the practice of encouraging or requiring physical site visits during the early stage of remedy implementation now appears to have become standardized (or at least far more common). Such site visits often consist of several days of on-site review and interviews at the parties' local operations, which can require intense preparation and data submission both beforehand and during. In addition, these site visits are now often prefaced by SAMR seeking additional consultation from important Chinese stakeholders that played a role in the merger review or could be impacted by the operation of the remedy, including Chinese customers (and under that category, distributors), competitors and trade associations.

For those cases that faced domestic challenges during the merger review, SAMR's continued/renewed consultation with the local industry may provide an additional opportunity for Chinese stakeholders to influence the scope of the remedy compliance. While the mature and experienced nature of SAMR's review team indicates that frivolous or unfounded complaints should not be entertained, certain critical comments or questions from important domestic stakeholders could draw SAMR's attention and additional scrutiny. Thus, while there would be no legal basis for SAMR to re-open the actual merits and substance of the remedies imposed during the legal review (at least absent materially changed circumstances), entities should still be cognizant of walking into a potentially challenging regulatory process in anticipation of complaints raised by local stakeholders.

During SAMR's site visit and interviews, companies should also watch out for other questions concerning the compliance with China's AML as a general matter (that is, outside the limited scope of the remedy obligations). Behavioral remedies are often imposed based on findings that the post-closing entity may have a dominant position in the relevant market(s). Thus, the site visit and industry consultation also give SAMR an opportunity to inspect whether the post-closing entity has abused such dominance — in a broader sense than being noncompliant with the remedies — or has in other ways violated the AML (for example, by entering into illegal resale-price-maintenance agreements with distributors). Certainly, data discovered during a site visit that points to such violations could lead to a full investigation at a later point. Although such risks were likely low in the MOFCOM era when the division was understaffed and responsible only for merger control activities, the consolidation of former conduct investigators from the NDRC and SAIC will only strengthen SAMR's ability to move quickly if it becomes concerned that the AML has been violated.

Enhanced Enforcement in Behavioral Remedies

The enhanced regulation of SAMR means that post-closing, the companies subject to behavioral remedies will face greater compliance scrutiny. This new consultation-based supervision approach significantly increases the burden of compliance for the post-closing entities and may lead to higher operational costs than the parties had previously expected.

From a deal-planning perspective, this means that parties that anticipate a difficult merger review by SAMR should assess the full potential cost of various behavioral remedies. While some remedies may look relatively innocuous on paper (such as maintaining historic levels of supply or agreeing not to enter into exclusive distribution arrangements), each remedy comes with material legal, operational, confidentiality and other responsibilities that may be in place for years.

Once a party has agreed to post-closing commitments and compliance, the merged entities should proactively develop a robust and reliable internal compliance program post-closing. Written compliance policies, manuals and trainings should be prepared and distributed to relevant employees, and care should be taken to demonstrate to SAMR and the monitoring trustee that the party is taking serious measures to ensure its own compliance (or risk even-greater ongoing scrutiny in an atmosphere of mistrust).

No merging or acquiring company ever considers the possibility of remedies lightly, but this recent ramp-up of enforcement and scrutiny for behavioral remedies in China should serve as a significant reminder of the potential burdens and costs that can come with such a remedy. It also highlights the importance of careful pre-planning and consideration when navigating the turbulent waters of China's merger review.

Footnotes

1 China's hold-separate remedy is a hybrid of structural and behavioral remedies, which is rarely imposed and often alleged to be driven more by industrial policy concerns than true competition concerns.

2 For example, it is understood that the supervision division now includes two former division directors of Review Division I. In the past few years, Review Division I has been responsible for reviewing of some of the most high-profile technology cases, including Broadcom/Brocade, Qualcomm/NXP, NXP/Freescale, Dell/EMC and HP/Samsung.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions